Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Boston Scientific Corp (BSX)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Boston Scientific Corp.
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 885725.
Total stock buying since 2015: $9,656,193.
Total stock sales since 2015: $558,426,311.
Total stock option exercises since 2015: $77,719,086.
Table 3. Detailed insider trading at Boston Scientific Corp (BSX) , Part 3
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2023-02-17 | Carruthers Wendy (EVP, Human Resources) | Option Ex | 2,250 | .00 | 0 |
| 2023-02-17 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 18,333 | .00 | 0 |
| 2023-02-17 | Fitzgerald Joseph Michael (EVP & Group Pres, Cardiology) | Option Ex | 4,166 | .00 | 0 |
| 2023-02-16 | Brown Vance R (SVP, GC and Corp. Secretary) | Option Ex | 1,838 | .00 | 0 |
| 2023-02-16 | Monson Jonathan (SVP, Global Controller and CAO) | Option Ex | 990 | .00 | 0 |
| 2023-02-16 | Butcher Arthur C (EVP& Grp Pres, MedSurg & APAC) | Option Ex | 2,545 | .00 | 0 |
| 2023-02-16 | Thepaut Eric Francis Yves (EVP & Pres, Eur, Mid-East, Afr) | Option Ex | 2,262 | .00 | 0 |
| 2023-02-16 | Sorenson John Bradley (EVP, Global Operations) | Option Ex | 1,272 | .00 | 0 |
| 2023-02-16 | Brennan Daniel J. (EVP and CFO) | Option Ex | 4,243 | .00 | 0 |
| 2023-02-16 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Sale | 1,409 | 46.79 | 65,927 |
| 2023-02-16 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Option Ex | 2,970 | .00 | 0 |
| 2023-02-16 | Carruthers Wendy (EVP, Human Resources) | Option Ex | 2,050 | .00 | 0 |
| 2023-02-16 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 16,264 | .00 | 0 |
| 2023-02-16 | Fitzgerald Joseph Michael (EVP & Group Pres, Cardiology) | Option Ex | 3,960 | .00 | 0 |
| 2023-02-15 | Brown Vance R (SVP, GC and Corp. Secretary) | Option Ex | 923 | .00 | 0 |
| 2023-02-15 | Monson Jonathan (SVP, Global Controller and CAO) | Option Ex | 739 | .00 | 0 |
| 2023-02-15 | Butcher Arthur C (EVP& Grp Pres, MedSurg & APAC) | Option Ex | 1,846 | .00 | 0 |
| 2023-02-15 | Thepaut Eric Francis Yves (EVP & Pres, Eur, Mid-East, Afr) | Option Ex | 1,846 | .00 | 0 |
| 2023-02-15 | Sorenson John Bradley (EVP, Global Operations) | Option Ex | 1,200 | .00 | 0 |
| 2023-02-15 | Brennan Daniel J. (EVP and CFO) | Sale | 7,572 | 47.14 | 356,928 |
| 2023-02-15 | Brennan Daniel J. (EVP and CFO) | Option Ex | 11,725 | 3.69 | 43,323 |
| 2023-02-15 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Option Ex | 2,031 | .00 | 0 |
| 2023-02-15 | Carruthers Wendy (EVP, Human Resources) | Option Ex | 1,661 | .00 | 0 |
| 2023-02-15 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 18,457 | .00 | 0 |
| 2023-02-15 | Fitzgerald Joseph Michael (EVP & Group Pres, Cardiology) | Option Ex | 4,615 | .00 | 0 |
| 2023-02-03 | Butcher Arthur C (EVP& Grp Pres, MedSurg & APAC) | Sale | 27,000 | 48.74 | 1,316,034 |
| 2023-02-03 | Butcher Arthur C (EVP& Grp Pres, MedSurg & APAC) | Option Ex | 15,034 | 16.79 | 252,345 |
| 2022-12-15 | Carruthers Wendy (EVP, Human Resources) | Sale | 22,500 | 46.62 | 1,048,995 |
| 2022-12-13 | Fitzgerald Joseph Michael (EVP & Group Pres, Cardiology) | Sale | 79,264 | 47.78 | 3,787,233 |
| 2022-12-13 | Fitzgerald Joseph Michael (EVP & Group Pres, Cardiology) | Option Ex | 79,264 | 7.39 | 585,760 |
| 2022-12-03 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Option Ex | 649 | .00 | 0 |
| 2022-11-29 | Connors Nelda J (Director) | Sale | 18,196 | 44.47 | 809,248 |
| 2022-11-18 | Thepaut Eric Francis Yves (EVP & Pres, Eur, Mid-East, Afr) | Sale | 14,952 | 42.72 | 638,779 |
| 2022-10-17 | Carruthers Wendy (EVP, Human Resources) | Sale | 13,322 | 40.52 | 539,740 |
| 2022-08-15 | Carruthers Wendy (EVP, Human Resources) | Sale | 7,500 | 42.03 | 315,262 |
| 2022-08-02 | Monson Jonathan (SVP, Global Controller and CAO) | Option Ex | 1,089 | .00 | 0 |
| 2022-08-02 | Connors Nelda J (Director) | Sale | 16,088 | 41.58 | 668,939 |
| 2022-08-01 | Thepaut Eric Francis Yves (EVP & Pres, Eur, Mid-East, Afr) | Sale | 20,676 | 40.99 | 847,509 |
| 2022-07-18 | Carruthers Wendy (EVP, Human Resources) | Sale | 7,500 | 38.00 | 285,000 |
| 2022-07-01 | Brown Vance R (SVP, GC and Corp. Secretary) | Option Ex | 4,035 | .00 | 0 |
| 2022-07-01 | Monson Jonathan (SVP, Global Controller and CAO) | Option Ex | 728 | .00 | 0 |
| 2022-06-24 | Carruthers Wendy (EVP, Human Resources) | Sale | 7,500 | 38.00 | 285,000 |
| 2022-05-16 | Carruthers Wendy (EVP, Human Resources) | Sale | 7,500 | 39.43 | 295,725 |
| 2022-05-01 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 2,062 | .00 | 0 |
| 2022-04-20 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Sale | 9,645 | 46.50 | 448,492 |
| 2022-04-19 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Sale | 10,989 | 45.50 | 499,999 |
| 2022-04-14 | Carruthers Wendy (EVP, Human Resources) | Sale | 7,500 | 44.47 | 333,517 |
| 2022-04-01 | Olson Scott (SVP & Pres, CRM, Diagnostics) | Sale | 700 | 44.55 | 31,184 |
| 2022-04-01 | Eddy Jodi Euerle (SVP, Chief Info & Digital Off.) | Sale | 2,779 | 45.00 | 125,055 |
| 2022-03-29 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Sale | 10,269 | 45.00 | 462,105 |
| 2022-03-29 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 5,411 | 16.31 | 88,253 |
| 2022-03-28 | Meredith Ian T (EVP Global Chief Med Officer) | Sale | 6,588 | 43.68 | 287,763 |
| 2022-03-22 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Sale | 11,236 | 44.50 | 500,002 |
| 2022-03-15 | Carruthers Wendy (EVP, Human Resources) | Sale | 7,500 | 42.34 | 317,587 |
| 2022-03-03 | Fitzgerald Joseph Michael (EVP & Pres, Cardiology) | Option Ex | 3,603 | .00 | 0 |
| 2022-03-02 | Brennan Daniel J. (EVP and CFO) | Sale | 11,029 | 44.03 | 485,650 |
| 2022-03-01 | Pierce David A (EVP Pres MedSurg) | Sale | 1,726 | 43.94 | 75,840 |
| 2022-02-28 | Brown Vance R (SVP, GC and Corp. Secretary) | Option Ex | 1,019 | .00 | 0 |
| 2022-02-28 | Olson Scott (SVP & Pres, CRM, Diagnostics) | Option Ex | 1,426 | .00 | 0 |
| 2022-02-28 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 1,019 | .00 | 0 |
| 2022-02-28 | Monson Jonathan (VP, Global Controller and CAO) | Option Ex | 815 | .00 | 0 |
| 2022-02-28 | Eddy Jodi Euerle (SVP, Chief Info & Digital Off.) | Option Ex | 1,426 | .00 | 0 |
| 2022-02-28 | Meredith Ian T (EVP Global Chief Med Officer) | Option Ex | 1,019 | .00 | 0 |
| 2022-02-28 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 1,528 | .00 | 0 |
| 2022-02-28 | Mackey Edward F (EVP, Operations) | Option Ex | 2,444 | .00 | 0 |
| 2022-02-28 | Thepaut Eric Francis Yves (EVP & Pres, Eur, Mid-East, Afr) | Option Ex | 1,833 | .00 | 0 |
| 2022-02-28 | Sorenson John Bradley (SVP, Global Supply Chain) | Option Ex | 1,222 | .00 | 0 |
| 2022-02-28 | Brennan Daniel J. (EVP and CFO) | Option Ex | 4,481 | .00 | 0 |
| 2022-02-28 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Option Ex | 2,037 | .00 | 0 |
| 2022-02-28 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 1,630 | .00 | 0 |
| 2022-02-28 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 18,330 | .00 | 0 |
| 2022-02-28 | Pierce David A (EVP Pres MedSurg) | Option Ex | 2,444 | .00 | 0 |
| 2022-02-28 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 1,630 | .00 | 0 |
| 2022-02-23 | Pierce David A (EVP Pres MedSurg) | Sale | 1,761 | 43.28 | 76,216 |
| 2022-02-22 | Brennan Daniel J. (EVP and CFO) | Sale | 53,182 | 42.75 | 2,273,636 |
| 2022-02-22 | Brennan Daniel J. (EVP and CFO) | Option Ex | 53,182 | 13.51 | 718,488 |
| 2022-02-22 | Pierce David A (EVP Pres MedSurg) | Sale | 1,884 | 42.55 | 80,164 |
| 2022-02-21 | Brown Vance R (SVP, GC and Corp. Secretary) | Option Ex | 779 | .00 | 0 |
| 2022-02-21 | Olson Scott (SVP & Pres, CRM, Diagnostics) | Option Ex | 1,090 | .00 | 0 |
| 2022-02-21 | Monson Jonathan (VP, Global Controller and CAO) | Option Ex | 623 | .00 | 0 |
| 2022-02-21 | Eddy Jodi Euerle (SVP, Chief Info & Digital Off.) | Option Ex | 935 | .00 | 0 |
| 2022-02-21 | Meredith Ian T (EVP Global Chief Med Officer) | Option Ex | 1,013 | .00 | 0 |
| 2022-02-21 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 1,714 | .00 | 0 |
| 2022-02-21 | Mackey Edward F (EVP, Operations) | Option Ex | 2,726 | .00 | 0 |
| 2022-02-21 | Sorenson John Bradley (SVP, Global Supply Chain) | Option Ex | 1,090 | .00 | 0 |
| 2022-02-21 | Brennan Daniel J. (EVP and CFO) | Option Ex | 3,661 | .00 | 0 |
| 2022-02-21 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Option Ex | 2,804 | .00 | 0 |
| 2022-02-21 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 1,558 | .00 | 0 |
| 2022-02-21 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 16,825 | .00 | 0 |
| 2022-02-21 | Pierce David A (EVP Pres MedSurg) | Option Ex | 2,493 | .00 | 0 |
| 2022-02-21 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 1,714 | .00 | 0 |
| 2022-02-21 | Fitzgerald Joseph Michael (EVP & Pres, Cardiology) | Option Ex | 3,895 | .00 | 0 |
| 2022-02-18 | Brown Vance R (SVP, GC and Corp. Secretary) | Option Ex | 741 | .00 | 0 |
| 2022-02-18 | Olson Scott (SVP & Pres, CRM, Diagnostics) | Option Ex | 1,037 | .00 | 0 |
| 2022-02-18 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 1,112 | .00 | 0 |
| 2022-02-18 | Monson Jonathan (VP, Global Controller and CAO) | Option Ex | 637 | .00 | 0 |
| 2022-02-18 | Eddy Jodi Euerle (SVP, Chief Info & Digital Off.) | Option Ex | 1,112 | .00 | 0 |
| 2022-02-18 | Meredith Ian T (EVP Global Chief Med Officer) | Option Ex | 1,037 | .00 | 0 |
| 2022-02-18 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 2,372 | .00 | 0 |
| 2022-02-18 | Mackey Edward F (EVP, Operations) | Option Ex | 25,942 | .00 | 0 |
| 2022-02-18 | Thepaut Eric Francis Yves (EVP & Pres, Eur, Mid-East, Afr) | Option Ex | 2,001 | .00 | 0 |
| 2022-02-18 | Sorenson John Bradley (SVP, Global Supply Chain) | Option Ex | 1,186 | .00 | 0 |
| 2022-02-18 | Brennan Daniel J. (EVP and CFO) | Option Ex | 3,706 | .00 | 0 |
| 2022-02-18 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Option Ex | 2,816 | .00 | 0 |
| 2022-02-18 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 1,853 | .00 | 0 |
| 2022-02-18 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 16,307 | .00 | 0 |
| 2022-02-18 | Pierce David A (EVP Pres MedSurg) | Sale | 2,354 | 42.88 | 100,939 |
| 2022-02-18 | Pierce David A (EVP Pres MedSurg) | Option Ex | 2,668 | .00 | 0 |
| 2022-02-18 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 1,779 | .00 | 0 |
| 2022-02-18 | Fitzgerald Joseph Michael (EVP & Pres, Cardiology) | Option Ex | 3,706 | .00 | 0 |
| 2022-02-17 | Brown Vance R (SVP, GC and Corp. Secretary) | Option Ex | 1,000 | .00 | 0 |
| 2022-02-17 | Olson Scott (SVP & Pres, CRM, Diagnostics) | Option Ex | 1,416 | .00 | 0 |
| 2022-02-17 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 1,583 | .00 | 0 |
| 2022-02-17 | Monson Jonathan (VP, Global Controller and CAO) | Option Ex | 1,000 | .00 | 0 |
| 2022-02-17 | Eddy Jodi Euerle (SVP, Chief Info & Digital Off.) | Option Ex | 1,500 | .00 | 0 |
| 2022-02-17 | Meredith Ian T (EVP Global Chief Med Officer) | Option Ex | 1,250 | .00 | 0 |
| 2022-02-17 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 2,833 | .00 | 0 |
| 2022-02-17 | Mackey Edward F (EVP, Operations) | Option Ex | 2,833 | .00 | 0 |
| 2022-02-17 | Thepaut Eric Francis Yves (EVP & Pres, Eur, Mid-East, Afr) | Option Ex | 2,500 | .00 | 0 |
| 2022-02-17 | Sorenson John Bradley (SVP, Global Supply Chain) | Option Ex | 1,500 | .00 | 0 |
| 2022-02-17 | Brennan Daniel J. (EVP and CFO) | Option Ex | 4,583 | .00 | 0 |
| 2022-02-17 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Option Ex | 3,333 | .00 | 0 |
| 2022-02-17 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 2,250 | .00 | 0 |
| 2022-02-17 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 18,333 | .00 | 0 |
| 2022-02-17 | Pierce David A (EVP Pres MedSurg) | Option Ex | 3,333 | .00 | 0 |
| 2022-02-17 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 2,166 | .00 | 0 |
| 2022-02-17 | Fitzgerald Joseph Michael (EVP & Pres, Cardiology) | Option Ex | 4,166 | .00 | 0 |
| 2022-02-16 | Brennan Daniel J. (EVP and CFO) | Sale | 12,187 | 43.70 | 532,584 |
| 2022-02-16 | Brennan Daniel J. (EVP and CFO) | Option Ex | 12,187 | 6.28 | 76,534 |
| 2022-02-16 | Pierce David A (EVP Pres MedSurg) | Sale | 1,956 | 43.81 | 85,692 |
| 2022-02-15 | Brown Vance R (SVP, GC and Corp. Secretary) | Option Ex | 923 | .00 | 0 |
| 2022-02-15 | Olson Scott (SVP & Pres, CRM, Diagnostics) | Option Ex | 1,292 | .00 | 0 |
| 2022-02-15 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 1,108 | .00 | 0 |
| 2022-02-15 | Monson Jonathan (VP, Global Controller and CAO) | Option Ex | 738 | .00 | 0 |
| 2022-02-15 | Eddy Jodi Euerle (SVP, Chief Info & Digital Off.) | Option Ex | 923 | .00 | 0 |
| 2022-02-15 | Meredith Ian T (EVP Global Chief Med Officer) | Option Ex | 1,108 | .00 | 0 |
| 2022-02-15 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 1,846 | .00 | 0 |
| 2022-02-15 | Mackey Edward F (EVP, Operations) | Option Ex | 2,769 | .00 | 0 |
| 2022-02-15 | Thepaut Eric Francis Yves (EVP & Pres, Eur, Mid-East, Afr) | Option Ex | 1,846 | .00 | 0 |
| 2022-02-15 | Sorenson John Bradley (SVP, Global Supply Chain) | Option Ex | 1,200 | .00 | 0 |
| 2022-02-15 | Brennan Daniel J. (EVP and CFO) | Sale | 9,136 | 43.47 | 397,141 |
| 2022-02-15 | Brennan Daniel J. (EVP and CFO) | Option Ex | 4,153 | .00 | 0 |
| 2022-02-15 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Option Ex | 2,030 | .00 | 0 |
| 2022-02-15 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 1,661 | .00 | 0 |
| 2022-02-15 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 18,457 | .00 | 0 |
| 2022-02-15 | Pierce David A (EVP Pres MedSurg) | Option Ex | 2,769 | .00 | 0 |
| 2022-02-15 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 1,661 | .00 | 0 |
| 2022-02-15 | Fitzgerald Joseph Michael (EVP & Pres, Cardiology) | Option Ex | 4,614 | .00 | 0 |
| 2022-02-07 | Sorenson John Bradley (SVP, Global Supply Chain) | Sale | 13,167 | 43.20 | 568,814 |
| 2022-02-01 | Meredith Ian T (EVP Global Chief Med Officer) | Option Ex | 3,131 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
of BSX listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Boston Scientific Corp (symbol BSX,
CIK number 885725) see
the Securities and Exchange Commission (SEC) website.